Pahayahay, Rolando D.
HRN: 20-37-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/20/2023
08/03/2023
IV
4.5 G
Q8h
T/C Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes